Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Alcohol Alcohol ; 56(6): 651-659, 2021 Oct 29.
Article in English | MEDLINE | ID: mdl-33418568

ABSTRACT

AIM: Investigate changes in alcohol use and related harm using the first multisite, controlled, longitudinal study of Managed Alcohol Programs (MAPs). MAPs provide regular doses of alcohol, accommodation, social supports and healthcare to unstably housed people with alcohol dependence. METHODS: A multisite, quasi-experimental, longitudinal study was conducted in day centres, shelters and residential programs for unstably housed people. There were 59 MAP participants from six Canadian cities and 116 local controls. Self-reported alcohol consumption and harms were assessed at 0-2, 6 and 12 months. Liver function test results were accessed for MAP participants. RESULTS: Both groups had similar reductions in mean drinks per day (MAP: -8.11; controls: -8.54 controls, P < 0.001) and days drinking per month (MAP: -2.51 days, P < 0.05; control: -4.81 days, P = 0.0001) over 6--12 months. Both reduced non-beverage alcohol consumption. MAP participants reported significantly fewer harms at both 0-2 and 6 months than controls. MAP participants had similar total consumption to controls, but spread out over more days (25.41 versus 19.64 days per month, P = 0.001). After leaving a MAP, participants' liver status deteriorated, with increases in both aspartate transaminase and bilirubin levels. MAP sites with effective policies on outside drinking drank less and had fewer harms. CONCLUSION: MAP participants drank less hazardously than controls, especially with effective management of non-MAP drinking. Reductions in alcohol use and harms occurred for both groups, although MAP participants reported fewer harms at 0-6 months. Departing an MAP was associated with deterioration in liver status. Although providing stable housing, MAPs did not worsen health or increase alcohol use.


Subject(s)
Alcohol Drinking/prevention & control , Alcoholism/rehabilitation , Harm Reduction , Program Evaluation , Adult , Aged , Aged, 80 and over , Alcohol Drinking/trends , Alcoholism/epidemiology , Canada/epidemiology , Case-Control Studies , Cities/epidemiology , Ethanol/administration & dosage , Female , Housing , Humans , Liver Function Tests , Longitudinal Studies , Male , Middle Aged , Social Support
2.
Harm Reduct J ; 16(1): 70, 2019 12 16.
Article in English | MEDLINE | ID: mdl-31842903

ABSTRACT

BACKGROUND: The twin problems of severe alcohol dependence and homelessness are associated with precarious living and multiple acute, social and chronic harms. While much attention has been focused on harm reduction services for illicit drug use, there has been less attention to harm reduction for this group. Managed alcohol programs (MAPs) are harm reduction interventions that aim to reduce the harms of severe alcohol use, poverty and homelessness. MAPs typically provide accommodation, health and social supports alongside regularly administered sources of beverage alcohol to stabilize drinking patterns and replace use of non-beverage alcohol (NBA). METHODS: We examined impacts of MAPs in reducing harms and risks associated with substance use and homelessness. Using case study methodology, data were collected from five MAPs in five Canadian cities with each program constituting a case. In total, 53 program participants, 4 past participants and 50 program staff were interviewed. We used situational analysis to produce a series of "messy", "ordered" and "social arenas" maps that provide insight into the social worlds of participants and the impact of MAPs. RESULTS: Prior to entering a MAP, participants were often in a revolving world of cycling through multiple arenas (health, justice, housing and shelters) where abstinence from alcohol is often required in order to receive assistance. Residents described living in a street-based survival world characterized by criminalization, unmet health needs, stigma and unsafe spaces for drinking and a world punctuated by multiple losses and disconnections. MAPs disrupt these patterns by providing a harm reduction world in which obtaining accommodation and supports are not contingent on sobriety. MAPs represent a new arena that focuses on reducing harms through provision of safer spaces and supply of alcohol, with opportunities for reconnection with family and friends and for Indigenous participants, Indigenous traditions and cultures. Thus, MAPs are safer spaces but also potentially spaces for healing. CONCLUSIONS: In a landscape of limited alcohol harm reduction options, MAPs create a new arena for people experiencing severe alcohol dependence and homelessness. While MAPs reduce precarity for participants, programs themselves remain precarious due to ongoing challenges related to lack of understanding of alcohol harm reduction and insecure program funding.


Subject(s)
Alcoholism/rehabilitation , Harm Reduction , Ill-Housed Persons , Adult , Aged , Alcoholism/psychology , Attitude to Health , Canada , Female , Homebound Persons/psychology , Humans , Male , Managed Care Programs , Middle Aged , Poverty , Social Support , Stereotyping
3.
Clin Radiol ; 67(9): 843-54, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22682703

ABSTRACT

AIMS: To evaluate the variance in current UK clinical practice and clinical outcomes for direct percutaneous radiologically inserted gastrostomy (RIG). MATERIALS AND METHODS: A prospective UK multicentre survey of RIG performed between October 2008 and August 2010 was performed through the British Society of Gastrointestinal and Abdominal Radiology (BSGAR). RESULTS: Data from 684 patients were provided by 45 radiologists working at 17 UK centres. Two hundred and sixty-three cases (40%) were performed with loop-retained catheters, and 346 (53%) with balloon-retained devices. Sixty percent of all patients experienced pain in the first 24 h, but settled in the majority thereafter. Early complications, defined as occurring in the first 24 h, included minor bleeding (1%), wound infection (3%), peritonism (2%), and tube misplacement (1%). Late complications, defined as occurring between day 2 and day 30 post-procedure, included mild pain (30%), persisting peritonism (2%), and 30 day mortality of 1% (5/665). Pre-procedural antibiotics or anti-methicillin-resistant Staphylococcus aureus (MRSA) prophylaxis did not affect the rate of wound infection, peritonitis, post-procedural pain, or mortality. Ninety-three percent of cases were performed using gastropexy. Gastropexy decreased post-procedural pain (p < 0.001), but gastropexy-related complications occurred in 5% of patients. However, post-procedure pain increased with the number of gastropexy sutures used (p < 0.001). The use of gastropexy did not affect the overall complication rate or mortality. Post-procedure pain increased significantly as tube size increased (p < 0.001). The use of balloon-retention feeding tubes was associated with more pain than the deployment of loop-retention devices (p < 0.001). CONCLUSION: RIG is a relatively safe procedure with a mortality of 1%, with or without gastropexy. Pain is the commonest complication. The use of gastropexy, fixation dressing or skin sutures, smaller tube sizes, and loop-retention catheters significantly reduced the incidence of pain. There was a gastropexy-related complication rate in 5% of patients. Neither pre-procedural antibiotics nor anti-MRSA prophylaxis affected the rate of wound infection.


Subject(s)
Gastrostomy/methods , Intubation, Gastrointestinal/methods , Radiography, Interventional/methods , Stomach/diagnostic imaging , Stomach/surgery , Surgery, Computer-Assisted/methods , Adolescent , Adult , Aged , Aged, 80 and over , Antibiotic Prophylaxis/methods , Female , Follow-Up Studies , Gastropexy/methods , Gastrostomy/adverse effects , Gastrostomy/instrumentation , Humans , Intubation, Gastrointestinal/adverse effects , Intubation, Gastrointestinal/instrumentation , Male , Methicillin-Resistant Staphylococcus aureus/drug effects , Middle Aged , Physical Fitness , Postoperative Complications/etiology , Prospective Studies , Survival Analysis , Treatment Outcome , United Kingdom , Young Adult
5.
Exp Neurol ; 160(2): 454-9, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10619562

ABSTRACT

Transforming growth factor alpha (TGFalpha) is a cytokine that belongs to the epidermal growth factor (EGF) family of growth factors. EGF has a fast and saturable entry from blood to brain that is inhibitable by TGFalpha (18). In this report, we studied the passage of TGFalpha from blood to brain after an i.v. bolus injection. Using radioactively labeled peptide, we found that TGFalpha had an apparent rate of entry of 0.7 microl/g/min. However, most of the TGFalpha was trapped in the capillary endothelial cells of the cerebral vasculature rather than entering the brain parenchyma. No saturation was detected. TGFalpha was relatively stable in blood for 20 min after i.v. injection, but dissociation of the isotope 125I was more evident in brain. The accumulation of TGFalpha in the cerebral vasculature was similar to that of amyloid-beta protein1-40. Therefore, we conclude that TGFalpha from the periphery interacts with the blood-brain barrier without substantial uptake into brain parenchyma. This raises the possibility that TGFalpha might be involved in intracranial vascular disorders such as angiopathy.


Subject(s)
Blood-Brain Barrier/physiology , Brain/metabolism , Transforming Growth Factor alpha/metabolism , Animals , Capillaries/physiology , Cerebrovascular Circulation/physiology , Endothelium, Vascular/physiology , Injections, Intravenous , Iodine Radioisotopes , Kinetics , Male , Mice , Mice, Inbred ICR , Regression Analysis , Transforming Growth Factor alpha/administration & dosage , Transforming Growth Factor alpha/blood
6.
Burns Incl Therm Inj ; 14(1): 21-4, 1988 Feb.
Article in English | MEDLINE | ID: mdl-3370511

ABSTRACT

A retrospective review of admissions to the Wessex Regional Burn Centre was made to determine the incidence and causes of childhood scalds during the periods 1960-65 and 1979-84. No reduction in numbers injured or significant change in causes were observed. Children aged 1-2 years old are still the most prone to scalding injury.


Subject(s)
Accidents, Home , Burns/epidemiology , Burns/etiology , Child, Preschool , Female , Humans , Infant , Male , Retrospective Studies , United Kingdom
7.
Exp Neurol ; 156(1): 165-71, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10192787

ABSTRACT

Previous work suggests that gp120 mediates the passage of HIV-1 and infected immune cells across the blood-brain barrier (BBB) by induction of adsorptive endocytosis (AE) in brain endothelial cells. Other work has suggested that cytokines may increase the permeability of the BBB to free virus or infected immune cells. Here, we investigated the ability of lipopolysaccharide (LPS), a bacterial wall toxin that stimulates the release of cytokines, to increase gp120 passage across the BBB by enhancement of AE and/or induction of BBB disruption. We found that LPS enhanced the passage of gp120 radioactively labeled with 125I (I-gp120) in a reversible, time-dependent, prostaglandin-independent manner that was not completely explained by disruption of the BBB. LPS also enhanced wheatgerm agglutinin mediated uptake of I-gp120 almost exclusively through the potentiation of AE. These results show that LPS or cytokines released by LPS can have a major effect on the permeability of the BBB to HIV-1gp120 both by stimulating AE and by inducing a disruption of the BBB. This suggests that bacterial infection or other inflammatory states could facilitate invasion of the CNS by HIV-1.


Subject(s)
Blood-Brain Barrier/physiology , Endocytosis/physiology , HIV Envelope Protein gp120/metabolism , Lipopolysaccharides/toxicity , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Blood-Brain Barrier/drug effects , Body Weight/drug effects , Brain Chemistry/drug effects , Cytokines/metabolism , Endocytosis/drug effects , Indomethacin/pharmacology , Injections, Intraperitoneal , Lipopolysaccharides/administration & dosage , Male , Mice , Mice, Inbred ICR , Permeability , Serum Albumin/metabolism , Wheat Germ Agglutinins/pharmacology
8.
J Gravit Physiol ; 7(2): P35-7, 2000 Jul.
Article in English | MEDLINE | ID: mdl-12697539

ABSTRACT

The purpose of the present study was to determine the feasibility of using a neuromechanical model of human locomotion based on a model previously published by Taga et al. to simulate gait at various speeds and gravitational levels. The results indicate that this model may be appropriate for studying walking at 1 G but not for higher speed or lower G locomotion.


Subject(s)
Computer Simulation , Gravitation , Locomotion , Models, Biological , Biomechanical Phenomena , Gait , Humans , Hypogravity , Joints , Musculoskeletal System , Running , Torque , Walking , Weightlessness
9.
J Gravit Physiol ; 7(2): P103-4, 2000 Jul.
Article in English | MEDLINE | ID: mdl-12697552

ABSTRACT

A role for neuromuscular activity in the maintenance of skeletal muscle properties has been well established. However, the role of activity-independent factors is more difficult to evaluate. We have used the spinal cord isolation model to study the effects of chronic inactivity on the mechanical properties of the hindlimb musculature in cats and rats. This model maintains the connectivity between the motoneurons and the muscle fibers they innervate, but the muscle unit is electrically "silent". Consequently, the measured muscle properties are activity-independent and thus the advantage of using this model is that it provides a baseline level (zero activity) from which regulatory factors that affect muscle cell homeostasis can be defined. In the present paper, we will present a brief review of our findings using the spinal cord isolation model related to muscle mechanical and fiber type properties.


Subject(s)
Muscle Fibers, Fast-Twitch/physiology , Muscle Fibers, Slow-Twitch/physiology , Muscle, Skeletal/innervation , Muscular Atrophy/physiopathology , Animals , Cats , Cordotomy , Electric Stimulation , Electromyography , Models, Animal , Muscle, Skeletal/physiology , Muscle, Skeletal/physiopathology , Myosin Heavy Chains/physiology , Rats , Spinal Cord
10.
Conf Proc IEEE Eng Med Biol Soc ; 2004: 4818-21, 2004.
Article in English | MEDLINE | ID: mdl-17271389

ABSTRACT

This paper overviews our recent efforts to develop robotic devices to help people relearn how to walk after spinal cord injury. Our efforts are focused on two goals. The first is to develop robotic devices that allow natural gait movements and good force control. We have developed a five degrees-of-freedom robot (PAM) that accommodates natural pelvic movement during walking. PAM uses pneumatic actuators and a nonlinear control algorithm to achieve good force control. We have also developed a novel leg robot, ARTHuR, which makes use of a linear motor to precisely apply forces to the leg during stepping. Our second goal is to develop optimal training algorithms for robotic gait training. Toward this goal, we have developed a small-scale robotic device that allows us to test locomotor training techniques in rodent models. We have also developed an instrumentation system that allows us to measure how experienced therapists manually assist limb movement. Finally, we are developing computational models of motor rehabilitation. These models suggest that assisting in stepping only as needed with a force-controlled robotic device may be an effective method for improving locomotor recovery.

SELECTION OF CITATIONS
SEARCH DETAIL